当前位置: X-MOL 学术Am. J. Bioethics › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Greater Than Minimal Risk, No Direct Benefit – Bridging Drug Trials and Novel Therapy in Pediatric Populations
The American Journal of Bioethics ( IF 17.0 ) Pub Date : 2020-03-24
Benjamin S. Wilfond, Devan M. Duenas, Liza-Marie Johnson

(2020). Greater Than Minimal Risk, No Direct Benefit – Bridging Drug Trials and Novel Therapy in Pediatric Populations. The American Journal of Bioethics: Vol. 20, No. 4, pp. 102-103.

中文翻译:

大于最小风险,没有直接收益–在儿科人群中架起药物试验和新颖疗法的桥梁

(2020)。大于最小的风险,没有直接的好处–在儿科人群中架起药物试验和新疗法的桥梁。美国生物伦理学杂志:第一卷。20,第4号,第102-103页。
更新日期:2020-03-24
down
wechat
bug